- RecruitingTherapeutic exploratory (Phase II)
J1A-MC-KDAF: A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants with Moderately-to-Severely Active Rheumatoid Arthritis
This study is testing a new medicine, peresolimab, for adults with moderate to severe rheumatoid arthritis. It aims to see if the medicine can reduce arthritis symptoms, like joint pain and swelling, better than a dummy treatment.
For: Rheumatoid Arthritis · Arthritis · Joint DiseasesHungary · Spain · Italy - RecruitingTherapeutic exploratory (Phase II)
KAN-101-03: A Phase 2a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of KAN-101 In Participants With Celiac Disease
This study is testing a new medicine, KAN-101, for people with coeliac disease. It wants to see if the medicine can help the gut lining heal and reduce symptoms, and if it's safe to use. Patients will receive either the medicine or a dummy treatment.
For: celiac diseaseFinland · Ireland · Poland - Not yet recruitingPHASE2
Prevent Cognitive Decline in GBA-associated Parkinson's Disease
This study is testing a new medicine called prasinezumab to see if it can slow down memory and thinking problems in people with Parkinson's disease who have a specific genetic change. It involves monthly infusions over two years.
For: Parkinson's DiseaseFrance · Germany · Italy - RecruitingPHASE3
Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
This study looks at a new way to treat liver scarring (cirrhosis) and fluid build-up (ascites). It tests if a special blood test can predict who will benefit most from regular albumin infusions, aiming to give effective treatment to the right patients.
For: Decompensated Cirrhosis and AscitesBelgium · Denmark · Germany